This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4B R4 R3
Orders and Observations Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
An example of a PGx haplotype report
{ "resourceType": "DiagnosticReport", "id": "example-pgx", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2><span>Pharmacogenetics Report</span> </h2><table><tr><td>Subject</td><td>Unable to get Patient Details</td></tr><tr><td>When For</td><td>15 Oct. 2016, 12:34:56 pm</td></tr><tr><td>Reported</td><td>20 Oct. 2016, 2:00:05 pm</td></tr></table><p><b>Report Details</b></p><table><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Reported</b></td></tr><tr><td><a><span>CYP2C9 gene product metabolic activity interpretation</span></a></td><td><span>Normal metabolizer</span></td><td>4 Apr. 2013, 1:30:10 am</td></tr></table></div>" }, "basedOn": [ { "reference": "ServiceRequest/example-pgx" } ], "status": "final", "code": { "coding": [ { "system": "https://system/PGxReport", "code": "PGxReport", "display": "Pharmacogenetics Report" } ], "text": "Pharmacogenetics Report" }, "subject": { "reference": "Patient/899962", "display": "Bob Smith" }, "effectiveDateTime": "2016-10-15T12:34:56+11:00", "issued": "2016-10-20T14:00:05+11:00", "performer": [ { "reference": "Organization/4829" } ], "result": [ { "reference": "Observation/example-phenotype" } ], "presentedForm": [ { "contentType": "application/pdf", "language": "en", "data": "cGRmSW5CYXNlNjRCaW5hcnk=", "hash": "571ef9c5655840f324e679072ed62b1b95eef8a0", "title": "Pharmacogenetics Report", "creation": "2016-10-20T20:00:00+11:00" } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.